Omesti Bhd (XKLS:9008) Short Percentage of Float


What is Omesti Bhd Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.


XKLS:9008 vs CTAS, CPRT, ULS: Short Percentage of Float Comparison

For the Specialty Business Services subindustry, Omesti Bhd's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omesti Bhd Short Percentage of Float vs Business Services Industry

For the Business Services industry and Industrials sector, Omesti Bhd's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Omesti Bhd's Short Percentage of Float falls into.



Omesti Bhd Business Description

Address No. 1 Persiaran Jalil 1, Bandar Bukit Jalil, 2-07-01 - Level 7, Plaza Bukit Jalil, Ho Hup Tower - Aurora Place, Kuala Lumpur, SGR, MYS, 57000
Omesti Bhd is focused on the delivery of technology solutions, systems integration services and the provision of recurring maintenance and managed services, predominantly for government and public sector customers. Its segments include Business Performance Services engages in provision of business performance improvement related services; Digital and Infrastructure Services engaged in the provision of a comprehensive range of tele/data communication, networking solutions and related services; and Healthcare Services engaged in the distribution of pharmaceutical products, vaccines and medical devices and provision of various medical services. The majority of the revenue is derived from Business Performance Services segment.